AAAAAA
Results:
1-12
|
Results: 12
Authors:
Mitterer, M
Lanthaler, AJ
Schnabel, B
Svaldi, M
Oduncu, F
Coser, P
Emmerich, B
Huemer, H
Straka, C
Citation: M. Mitterer et al., Peripheral blood monoclonal B-cells predict the event free survival in multiple myeloma, LEUK LYMPH, 41(3-4), 2001, pp. 387-395
Authors:
Svaldi, M
Tappa, C
Gebert, U
Bettini, D
Fabris, P
Franzelin, F
Osele, L
Mitterer, M
Citation: M. Svaldi et al., Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy andautologous stem cell transplantation, ANN HEMATOL, 80(7), 2001, pp. 393-397
Authors:
Svaldi, M
Lanthaler, A
Venturi, R
Coser, P
Mitterer, M
Citation: M. Svaldi et al., Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloidleukemia, LEUKEMIA, 15(4), 2001, pp. 695-695
Authors:
Ladetto, M
Sametti, S
Donovan, JW
Ferrero, D
Astolfi, M
Mitterer, M
Ricca, I
Drandi, D
Corradini, P
Coser, P
Pileri, A
Gribben, JC
Tarella, C
Citation: M. Ladetto et al., A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients, EXP HEMATOL, 29(2), 2001, pp. 183-193
Authors:
Jumaa, H
Mitterer, M
Reth, M
Nielsen, PJ
Citation: H. Jumaa et al., The absence of SLP65 sand Btk blocks B cell development at the preB cell receptor-positive stage, EUR J IMMUN, 31(7), 2001, pp. 2164-2169
Authors:
Svaldi, M
Hirber, J
Lanthaler, AI
Mayr, O
Faes, S
Peer, E
Mitterer, M
Citation: M. Svaldi et al., Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients, BR J HAEM, 115(1), 2001, pp. 53-57
Authors:
Willeit, J
Kiechl, S
Oberhollenzer, F
Rungger, G
Egger, G
Bonora, E
Mitterer, M
Muggeo, M
Citation: J. Willeit et al., Distinct risk profiles of early and advanced atherosclerosis - Prospectiveresults from the Bruneck Study, ART THROM V, 20(2), 2000, pp. 529-537
Authors:
Jumaa, H
Wollscheid, B
Mitterer, M
Wienands, J
Reth, M
Nielsen, PJ
Citation: H. Jumaa et al., Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65, IMMUNITY, 11(5), 1999, pp. 547-554
Authors:
Mitterer, M
Pescosta, N
Mc Quain, C
Gebert, U
Oberkofler, E
Coser, P
Knecht, H
Citation: M. Mitterer et al., Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-celllymphoma, ANN ONCOL, 10(2), 1999, pp. 231-234
Authors:
Mitterer, M
Lanthaler, AJ
Mair, W
Giacomuzzi, K
Coser, P
Citation: M. Mitterer et al., Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR, HAEMATOLOG, 84(3), 1999, pp. 204-207
Authors:
Kiechl, S
Muigg, A
Santer, P
Mitterer, M
Egger, G
Oberhollenzer, M
Oberhollenzer, F
Mayr, A
Gasperi, A
Poewe, W
Willeit, J
Citation: S. Kiechl et al., Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease, CIRCULATION, 99(5), 1999, pp. 614-619
Authors:
Mitterer, M
Oduncu, F
Lanthaler, AJ
Drexler, E
Amaddii, G
Fabris, P
Emmerich, B
Coser, P
Straka, C
Citation: M. Mitterer et al., The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients, BR J HAEM, 106(3), 1999, pp. 737-743
Risultati:
1-12
|